Research Article
Prognostic Values of Transforming Growth Factor-Beta Subtypes in Ovarian Cancer
Table 1
Correlation of TGF-β subtypes with OS and PFS in ovarian cancer patients with different clinical stages of disease.
| TGF-β subtypes | Clinical stages | Cases | OS | value | Cases | PFS | value | HR (95% CI) | HR (95% CI) |
| TGF-β1 | I+II | 135 | 2.62 (1.20-5.73) | 0.0012 | 163 | 2.40 (1.36-4.23) | 0.0018 | III+IV | 1220 | 1.11 (0.94-1.30) | 0.21 | 1081 | 0.85 (0.74-0.98) | 0.023 |
| TGF-β2 | I+II | 135 | 0.40 (0.18-0.98) | 0.021 | 163 | 0.72 (0.41-1.28) | 0.26 | III + IV | 1220 | 1.21 (1.04-1.40) | 0.011 | 1081 | 1.29 (1.12-1.48) | 0.0004 |
| TGF-β3 | I+II | 135 | 1.83 (0.69-4.88) | 0.22 | 163 | 1.29 (0.69-2.43) | 0.43 | III+IV | 1220 | 1.14 (0.98-1.33) | 0.095 | 1081 | 1.36 (1.18-1.56) | 0.001 |
| TGF-β4 | I+II | 135 | 2.96 (1.28-6.85) | 0.0079 | 163 | 2.18 (1.22-3.87) | 0.0068 | III+IV | 1220 | 0.91 (0.78-1.07) | 0.26 | 1081 | 1.17 (1.02-1.35) | 0.029 |
|
|
|